Medicare Enrolled
Dr. Fariborz Nazari-Adli, M.D.
Family Medicine · Baytown, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Nazari-Adli from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Nazari-Adli?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Nazari-Adli
Dr. Fariborz Nazari-Adli is a family medicine specialist in Baytown, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Nazari-Adli performed 1,255 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Nazari-Adli received a total of $24,444 from 84 pharmaceutical and/or device companies across 1686 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Nazari-Adli is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 23% volume in TX
$24,444 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗1,255
Medicare services
Top 23% in TX for family medicine
Not available
Unique patients (not deduplicated)
$42
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
391 | $67 | $98 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
158 | $39 | $160 |
| Remote vital sign monitoring management, each additional 20 minutes This code covers the time spent by a provider managing patient data from remote vital sign monitoring devices. It applies to each additional 20-minute increment beyond the initial monthly service period. |
88 | $32 | $130 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
87 | $10 | $25 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
85 | $0 | $20 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
74 | $39 | $200 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
54 | $3 | $15 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
53 | $8 | $19 |
| Ultrasound of arm and leg arteries A non-invasive imaging test that uses sound waves to examine the blood vessels in the arms and legs. It evaluates blood flow and checks for blockages or other vascular issues. |
50 | $103 | $280 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
47 | $89 | $131 |
| Methylprednisolone acetate injection, 80 mg An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication. |
39 | $8 | $60 |
| Blood glucose test using hand-held instrument A test that measures the level of sugar in the blood using a portable device. The result helps monitor blood glucose levels. |
36 | $3 | $19 |
| Autonomic nervous system testing with heart rate response to deep breathing This test evaluates the function of the autonomic nervous system by measuring how the heart rate changes in response to deep breathing. |
25 | $45 | $410 |
| Autonomic nervous system function test This test evaluates how well the sympathetic nervous system is functioning. It assesses the automatic control of bodily processes such as heart rate and blood pressure. |
25 | $68 | $410 |
| Quadrivalent influenza vaccine, cell culture-derived A flu shot that protects against four strains of the influenza virus. It is produced using cell culture technology rather than traditional egg-based methods. |
15 | $32 | $40 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
15 | $24 | $25 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
13 | $17 | $45 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$24,444
Total received (2018-2024)
Avg $3,492/year across 7 years
Top 1% in TX for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
84
Companies
1,686
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,702
2023
$3,837
2022
$3,245
2021
$4,568
2020
$3,208
2019
$3,144
2018
$2,740
Payments by company (2024)
AstraZeneca Pharmaceuticals LP
$534
Dexcom, Inc.
$395
Bayer Healthcare Pharmaceuticals Inc.
$344
ABBVIE INC.
$340
Lilly USA, LLC
$291
Amgen Inc.
$227
Paratek Pharmaceuticals, Inc.
$145
Astellas Pharma US Inc
$145
Novo Nordisk Inc
$138
Otsuka America Pharmaceutical, Inc.
$135
Boehringer Ingelheim Pharmaceuticals, Inc.
$119
Medtronic, Inc.
$108
Antares Pharma, Inc.
$73
Esperion Therapeutics, Inc.
$68
Actelion Pharmaceuticals US, Inc.
$64
PFIZER INC.
$64
Kowa Pharmaceuticals America, Inc.
$52
Tolmar, Inc.
$49
Exact Sciences Corporation
$47
Abbott Laboratories
$46
Phathom Pharmaceuticals, Inc.
$43
IDORSIA PHARMACEUTICALS US INC
$38
Currax Pharmaceuticals LLC
$34
GlaxoSmithKline, LLC.
$30
IRONWOOD PHARMACEUTICALS, INC
$27
Lundbeck LLC
$23
Merck Sharp & Dohme LLC
$23
Insulet Corporation
$23
CeQur Corporation
$21
Inspire Medical Systems, Inc.
$19
Boston Scientific Corporation
$19
Gilead Sciences, Inc.
$15
Top 3 companies account for 34.4% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$2,123
Novo Nordisk Inc
$1,358
Lilly USA, LLC
$1,326
Biohaven Pharmaceuticals, Inc.
$1,295
PFIZER INC.
$1,219
Dexcom, Inc.
$941
GlaxoSmithKline, LLC.
$854
ABBVIE INC.
$837
Boehringer Ingelheim Pharmaceuticals, Inc.
$798
Amgen Inc.
$793
Mannkind Corporation
$792
Paratek Pharmaceuticals, Inc.
$733
Otsuka America Pharmaceutical, Inc.
$605
Bayer Healthcare Pharmaceuticals Inc.
$569
Merck Sharp & Dohme Corporation
$546
Sunovion Pharmaceuticals Inc.
$538
MannKind Corporation
$491
Medtronic, Inc.
$467
Bayer HealthCare Pharmaceuticals Inc.
$444
Kowa Pharmaceuticals America, Inc.
$431
AbbVie Inc.
$373
Allergan, Inc.
$341
Horizon Therapeutics plc
$332
Takeda Pharmaceuticals U.S.A., Inc.
$326
Teva Pharmaceuticals USA, Inc.
$324
Supernus Pharmaceuticals, Inc.
$319
Esperion Therapeutics, Inc.
$318
Insulet Corporation
$293
Janssen Pharmaceuticals, Inc
$286
Antares Pharma, Inc.
$262
Endo Pharmaceuticals Inc.
$243
Astellas Pharma US Inc
$235
SANOFI-AVENTIS U.S. LLC
$230
Amarin Pharma Inc.
$228
Allergan Inc.
$217
Merck Sharp & Dohme LLC
$211
Abbott Laboratories
$190
Currax Pharmaceuticals LLC
$180
DEXCOM, INC.
$151
Medtronic MiniMed, Inc.
$121
EISAI INC.
$120
Exact Sciences Corporation
$106
Cumberland Pharmaceuticals, Inc.
$96
Lundbeck LLC
$96
IDORSIA PHARMACEUTICALS US INC
$91
Tandem Diabetes Care, Inc.
$91
Novartis Pharmaceuticals Corporation
$89
Indivior Inc.
$86
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$82
Eisai Inc.
$77
Mylan Specialty L.P.
$75
Ironwood Pharmaceuticals, Inc
$72
Actelion Pharmaceuticals US, Inc.
$64
JAZZ PHARMACEUTICALS INC.
$59
Philips Electronics North America Corporation
$57
RedHill Biopharma Inc.
$51
Global Blood Therapeutics, Inc.
$50
Tolmar, Inc.
$49
Scilex Pharmaceuticals Inc.
$45
IRONWOOD PHARMACEUTICALS, INC
$45
Phathom Pharmaceuticals, Inc.
$43
Melinta Therapeutics, Inc.
$42
Boston Scientific Corporation
$39
Nabriva Therapeutics, plc
$38
Masimo Corporation
$38
Celgene Corporation
$37
ERMI Inc.
$34
Biohaven Pharmaceutical Holding Company Ltd.
$34
Arbor Pharmaceuticals, Inc.
$31
Horizon Pharma plc
$26
Ferring Pharmaceuticals Inc.
$26
CeQur Corporation
$21
Orexo US, Inc.
$20
Assertio Therapeutics, Inc.
$19
Inspire Medical Systems, Inc.
$19
Vertical Pharmaceuticals, LLC
$18
Acerus Pharmaceuticals Corporation
$17
Exeltis, USA Inc.
$17
ARBOR PHARMACEUTICALS, INC.
$17
Gilead Sciences, Inc.
$15
Iroko Pharmaceuticals, LLC
$14
Clarus Therapeutics Inc.
$14
Azurity Pharmaceuticals, Inc.
$14
VIVUS LLC
$11
Top 3 companies account for 19.7% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · ABILIFY MAINTENA · AFREZZA · AIRSUPRA · AJOVY · ANORO · ANORO ELLIPTA · APTIOM · Aimovig · Amitiza · BAQSIMI · BELSOMRA · BREO · BREZTRI · BROVANA · BYDUREON · BYSTOLIC · Baxdela · Belviq · BodyGuardian · CHANTIX · COLOGUARD · COLOGUARD DNA CAPTURE REAGENTS · CONTRAVE · CeQur Simplicity · Cologuard Collection Kit · DEXCOM CGM · DEXCOM G6 TRANSMITTER · DEXCOM G7 GSS (161) · DIFICID · DUEXIS · Dexcom CGM · Dexcom G6 Transmitter · EDEX · ELIQUIS · EMGALITY · EUCRISA · EUFLEXXA · EVENITY · Edarbi · Edarbyclor · FARXIGA · FLECTOR · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre 2 · GATTEX · Guardian Connect · HUMALOG · INPEN SMART INSULIN DELIVERY SYSTEM · INSPIRE · JANUVIA · JARDIANCE · JATENZO · KRYSTEXXA · Kerendia · Kristalose 20gm · LEQVIO · LINZESS · LIVALO · LONHALA MAGNAIR · LORZONE · LYRICA · LYUMJEV · Linzess · Livalo · MINIMED 770G · MINIMED 780G · MOUNJARO · MYRBETRIQ · Minimed 630G · Minimed 670G System · Motegrity · Myrbetriq · NASCOBAL · NEXLETOL · NOCDURNA · NURTEC ODT · NUZYRA · Natesto · OFEV · ONZETRA XSAIL · OPSUMIT · OXBRYTA · Omeclamox · Omnipod · Otezla · Ozempic · PENNSAID · PRALUENT · PREVNAR 20 · Patient SafetyNet System · Perforomist · ProAir Digihaler · Prolia · QULIPTA · QUVIVIQ · Qsymia · RAYOS · REXULTI · RYBELSUS · Repatha · Rybelsus · SEEBRI · SEGLENTIS · SHINGRIX · SIVEXTRO · SLYND · SOLIQUA · SOLIQUA 100/33 · STEGLATRO · STEGLUJAN · STIOLTO RESPIMAT · SUBLOCADE · SUBOXONE SUBLINGUAL FILM · SUNOSI · SYMBICORT · Saxenda · Seglentis · TIVORBEX · TOUJEO · TRELEGY ELLIPTA · TROKENDI XR · TRULICITY · Talicia · Tresiba · Trintellix · UBRELVY · UTIBRON · UTIBRON NEOHALER · Uloric · Utibron · VERQUVO · VOQUEZNA · VRAYLAR · VYEPTI · Vascepa · Veozah · Victoza · XARELTO · XIAFLEX · XIFAXAN · XYOSTED · Xenleta · Xultophy 100/3.6 · Yupelri · ZERBAXA · ZORYVE · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zipsor · Zubsolv · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Family medicine physicians in nearby ZIP areas
621
County median income
$73,104
Nearest hospital to ZIP centroid (approximate)
HOUSTON METHODIST BAYTOWN HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Nazari-Adli is a clinical cardiology specialist, with above-average Medicare volume (top 23% in TX), with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Nazari-Adli experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Nazari-Adli performed 391 office visit, established patient (20-29 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Nazari-Adli receive payments from pharmaceutical companies?
Yes. Dr. Nazari-Adli received a total of $24,444 from 84 companies across 1,686 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Nazari-Adli's costs compare to other family medicine physicians in Baytown?
Dr. Nazari-Adli's average Medicare payment per service is $42. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Nazari-Adli) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicine Physicians in Baytown
Browse family medicine physicians in Baytown ranked by procedure volume and transparency data.
Highest volume
Top Family Medicine Physicians in TX
Family medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicine Physicians in TX
Which TX family medicine physicians receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology